Moreover, CXCR1 and CXCR2 antagonist are also used to treat human melanoma (18), lung (19), breast (20), and pancreatic cancer (21) growth by inhibiting tumor cell proliferation and suppression of angiogenesis and metastasis. Here, CXCR2 is linked to melanoma.